Samina Khan's most recent trade in Reata Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 352 Class A common stock done at an average price of $81.4 . Disclosure was reported to the exchange on May 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 81.37 per share. | 15 May 2023 | 352 | 39,491 (0%) | 0% | 81.4 | 28,642 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 85.32 per share. | 15 May 2023 | 288 | 39,843 (0%) | 0% | 85.3 | 24,572 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 83.46 per share. | 07 Mar 2023 | 3,961 | 40,131 (0%) | 0% | 83.5 | 330,585 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.32 per share. | 02 Mar 2023 | 25,000 | 71,905 (0%) | 0% | 27.3 | 683,000 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 85.02 per share. | 02 Mar 2023 | 18,956 | 49,554 (0%) | 0% | 85.0 | 1,611,639 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 83.70 per share. | 02 Mar 2023 | 3,395 | 68,510 (0%) | 0% | 83.7 | 284,162 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 87.36 per share. | 02 Mar 2023 | 2,813 | 44,092 (0%) | 0% | 87.4 | 245,744 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 85.38 per share. | 02 Mar 2023 | 2,649 | 46,905 (0%) | 0% | 85.4 | 226,172 | Class A common stock |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 47,738 | 47,738 | - | - | Employee Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Samina Khan | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 11,756 | 46,905 (0%) | 0% | 0 | Class A common stock |